Suppr超能文献

对于具有高溶解度和高渗透性的P-糖蛋白底物,渗透性在其体内肠道吸收过程中起主导作用。

Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeability.

作者信息

Cao Xianhua, Yu Lawrence X, Barbaciru Catalin, Landowski Christopher P, Shin Ho-Chul, Gibbs Seth, Miller Heather A, Amidon Gordon L, Sun Duxin

机构信息

Division of Pharmaceutics, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, USA.

出版信息

Mol Pharm. 2005 Jul-Aug;2(4):329-40. doi: 10.1021/mp0499104.

Abstract

Three purposes are presented in this study: (1) to study the in vivo regional dependent intestinal absorption of a P-gp substrate with high solubility and high permeability, (2) to study the gene expression difference in the various regions of the intestine, and (3) to study the contributions of P-gp or any other transporters for the absorption of a P-gp substrate. The in vivo permeability of verapamil and propranolol were determined by single-pass in situ intestinal perfusion in rat. The gene expression profiles were measured using Affymetrix GeneChip. Correlation analysis between drug in vivo permeability and expression of 3500 genes was performed with nonparametric bootstrap and ANOVA analysis. The permeability of verapamil and propranolol did not demonstrate regional dependency even though significant differences in gene expression were observed in various regions of the intestine. Verapamil permeability significantly correlates with propranolol permeability in both jejunum and ileum, but did not correlate with the permeability of other hydrophilic compounds (valacyclovir, acyclovir, and phenylalanine). Four different regions (duodenum, jejunum, ileum, and colon) showed distinct gene expression patterns with more than 70-499 genes showing at least 5-fold expression differences. Interestingly, P-gp expression is gradually increased by 6-fold from the duodenum to colon. Despite the distinct gene expression patterns in the various regions of the intestine, verapamil permeability did not correlate with any gene expression from 3500 expressed genes in the intestine. A 2-6-fold P-gp expression difference did not seem to associate verapamil permeability in the various intestinal regions in vivo. These data suggest that P-gp plays a minimal role in the in vivo intestinal absorption process of verapamil with high water solubility and high membrane permeability. The intestinal absorption of verapamil in vivo is primarily dominated by its high permeability. However, it is important to note that the findings in this paper do not undermine the importance of P-gp in oral drug bioavailability, drug disposition from the liver, drug efflux from the blood-brain barrier, and drug-drug interaction.

摘要

本研究提出了三个目的

(1)研究一种具有高溶解度和高渗透性的P-糖蛋白底物在体内的区域依赖性肠道吸收;(2)研究肠道不同区域的基因表达差异;(3)研究P-糖蛋白或任何其他转运蛋白对P-糖蛋白底物吸收的贡献。维拉帕米和普萘洛尔的体内渗透性通过大鼠单通道原位肠道灌注测定。基因表达谱使用Affymetrix基因芯片进行测量。采用非参数自助法和方差分析对3500个基因的药物体内渗透性与表达进行相关性分析。尽管在肠道不同区域观察到基因表达存在显著差异,但维拉帕米和普萘洛尔的渗透性并未表现出区域依赖性。维拉帕米在空肠和回肠的渗透性与普萘洛尔的渗透性显著相关,但与其他亲水性化合物(伐昔洛韦、阿昔洛韦和苯丙氨酸)的渗透性无关。四个不同区域(十二指肠、空肠、回肠和结肠)呈现出不同的基因表达模式,有70 - 499个以上基因表现出至少5倍的表达差异。有趣的是,从十二指肠到结肠,P-糖蛋白表达逐渐增加6倍。尽管肠道不同区域有不同的基因表达模式,但维拉帕米的渗透性与肠道中3500个表达基因的任何基因表达均无相关性。2 - 6倍的P-糖蛋白表达差异似乎与体内不同肠道区域的维拉帕米渗透性无关。这些数据表明,P-糖蛋白在高水溶性和高膜渗透性的维拉帕米体内肠道吸收过程中起的作用最小。维拉帕米的体内肠道吸收主要由其高渗透性主导。然而,需要注意的是,本文的研究结果并不削弱P-糖蛋白在口服药物生物利用度、肝脏药物处置、血脑屏障药物外排以及药物相互作用中的重要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验